Cromwell Holdings’s Roivant Sciences ROIV Stock Holding History

Cromwell Holdings’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.79K	Buy	107 +61	+133%	+$1.8K	﹤0.01%	716
2026 Q1	$1.27K	Hold	46	–	–	﹤0.01%	805
2025 Q4	$998	Hold	46	–	–	﹤0.01%	829
2025 Q3	$696	Hold	46	–	–	﹤0.01%	918
2025 Q2	$518	Buy	+46	New	+$499	﹤0.01%	961

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Cromwell Holdings's ROIV Position: Q2 2026 in Review

Cromwell Holdings increased its Roivant Sciences (ROIV) stake by 133% in Q2 2026, buying an estimated $1.8K and bringing the position to 107 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

Cromwell Holdings first reported a position in ROIV in Q2 2025 and has held it in 5 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Cromwell Holdings held 107 shares of Roivant Sciences worth $3.79K as of Q2 2026.
Cromwell Holdings bought 61 Roivant Sciences shares in Q2 2026, an estimated $1.8K.
Roivant Sciences made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #716 holding.
Cromwell Holdings first reported a position in Roivant Sciences in Q2 2025 and has held it in 5 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.